BerandaCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Tutup sebelumnya
$5,78
Rentang tahun
$4,43 - $19,40
Kapitalisasi pasar
3,40Â jt USD
Volume Rata-Rata
9,79Â rb
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 10,00Â rb | -37,50% |
Biaya operasional | 2,19Â jt | -68,12% |
Laba bersih | -1,96Â jt | 67,56% |
Margin laba bersih | -19,57Â rb | 48,09% |
Penghasilan per saham | -0,18 | 97,55% |
EBITDA | -2,18Â jt | 68,18% |
Tarif pajak efektif | 9,69% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,98Â jt | -49,83% |
Total aset | 5,38Â jt | -56,94% |
Total liabilitas | 6,35Â jt | -22,55% |
Total ekuitas | -970,00 rb | — |
Saham yang beredar | 6,29 jt | — |
Harga terhadap nilai buku | -12,84 | — |
Tingkat pengembalian aset | -80,21% | — |
Tingkat pengembalian modal | -32.014,71% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -1,96Â jt | 67,56% |
Kas dari operasi | -3,07Â jt | 24,01% |
Kas dari investasi | — | — |
Kas dari pembiayaan | -1,00Â rb | 98,00% |
Perubahan kas bersih | -3,02Â jt | 28,48% |
Arus kas bebas | -2,31Â jt | 8,20% |
Tentang
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Wikipedia
Didirikan
13 Agu 1996
Kantor pusat
Situs
Karyawan
12
